Specific neuroimmunophilin ligands to treat neurodegenerative disease.
Fletcher
L
L
D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism; D004195:Disease Models, Animal; D006360:Heat-Shock Proteins / Q000378:metabolism; D006801:Humans; D006892:Hydroxydopamines / Q000627:therapeutic use*; D008024:Ligands; D019636:Neurodegenerative Diseases / Q000188:drug therapy*; D010300:Parkinson Disease / Q000188:drug therapy; D019696:Peptidylprolyl Isomerase / Q000378:metabolism; D016559:Tacrolimus / Q000627:therapeutic use*; D022021:Tacrolimus Binding Proteins
D002352:Carrier Proteins; D004268:DNA-Binding Proteins; D006360:Heat-Shock Proteins; D006892:Hydroxydopamines; D008024:Ligands; D022021:Tacrolimus Binding Proteins; D019696:Peptidylprolyl Isomerase; D016559:Tacrolimus